310 related articles for article (PubMed ID: 24817039)
1. Circulating tumour cells--a bona fide cause of metastatic cancer.
Caixeiro NJ; Kienzle N; Lim SH; Spring KJ; Tognela A; Scott KF; de Souza P; Becker TM
Cancer Metastasis Rev; 2014 Sep; 33(2-3):747-56. PubMed ID: 24817039
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumour cells in breast cancer--review.
Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
4. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
Paterlini-Bréchot P
Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.
Santos MF; Mannam VK; Craft BS; Puneky LV; Sheehan NT; Lewis RE; Cruse JM
Exp Mol Pathol; 2014 Jun; 96(3):367-74. PubMed ID: 24731923
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
8. Profiling circulating tumour cells and other biomarkers of invasive cancers.
Poudineh M; Sargent EH; Pantel K; Kelley SO
Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells: insights into tumour heterogeneity.
Hayes DF; Paoletti C
J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916
[TBL] [Abstract][Full Text] [Related]
10. The origin of prostate metastases: emerging insights.
Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
[TBL] [Abstract][Full Text] [Related]
11. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
Hayashi N; Yamauchi H
Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809
[TBL] [Abstract][Full Text] [Related]
12. [Circulating tumor cells: detection, characterization and clinical impact].
Gilles C; Collignon J; Noël A; Jerusalem G; Foidart JM
Rev Med Liege; 2011; 66(5-6):279-84. PubMed ID: 21826962
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.
Lim SH; Becker TM; Chua W; Ng WL; de Souza P; Spring KJ
J Clin Pathol; 2014 Oct; 67(10):848-53. PubMed ID: 25008452
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgery.
Lim SH; Spring KJ; de Souza P; MacKenzie S; Bokey L
Eur J Surg Oncol; 2015 Mar; 41(3):309-14. PubMed ID: 25564251
[TBL] [Abstract][Full Text] [Related]
15. Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Dasgupta A; Lim AR; Ghajar CM
Mol Oncol; 2017 Jan; 11(1):40-61. PubMed ID: 28085223
[TBL] [Abstract][Full Text] [Related]
16. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
Danova M; Torchio M; Mazzini G
Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
[TBL] [Abstract][Full Text] [Related]
17. Advances in genomic characterization of circulating tumor cells.
Magbanua MJ; Park JW
Cancer Metastasis Rev; 2014 Sep; 33(2-3):757-69. PubMed ID: 24867683
[TBL] [Abstract][Full Text] [Related]
18. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
Menyailo ME; Tretyakova MS; Denisov EV
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
[TBL] [Abstract][Full Text] [Related]
20. Pre-metastatic niches: organ-specific homes for metastases.
Peinado H; Zhang H; Matei IR; Costa-Silva B; Hoshino A; Rodrigues G; Psaila B; Kaplan RN; Bromberg JF; Kang Y; Bissell MJ; Cox TR; Giaccia AJ; Erler JT; Hiratsuka S; Ghajar CM; Lyden D
Nat Rev Cancer; 2017 May; 17(5):302-317. PubMed ID: 28303905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
